LD-2 disclosure · 2nd Quarter - Report
PHLOW CORPORATION
Client
- Location
- Virginia · United States of America
Registrant
- Description
- Generic Pharmaceutical Manufacturing
- Location
- Richmond, Virginia, United States of America
Lobbying activities
3 issuesBudget/Appropriations
FY27 Labor, Health and Human Services, Education, and Related Agencies Appropriations (H.R.9260); FY27 Department of Defense Appropriations (H.R.9495)
LobbyistsVALERIE HARDIN JEWETT · JOHN FUNDERBURK
TargetedSENATE · HOUSE OF REPRESENTATIVES · Office of Management & Budget (OMB) · Defense, Dept of (DOD) · Health & Human Services, Dept of (HHS) · Natl Economic Council (NEC)
Health Issues
Administrations activities related to supply chain and domestic capacity; Department of Defense activities related to pharmaceutical and medical countermeasure supply chain for the warfighter; S.1784, Mapping America's Pharmaceutical Supply (MAPS) Act, provisions related to the improvement of coordination of Federal efforts to identify and mitigate health and national security risks; H.R. 4191, Mapping America's Pharmaceutical Supply (MAPS) Act, (identical legislation); S.2062, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act, provisions related to improving supply chain resiliency for critical drug products with vulnerable supply chains; H.R.3966, Rolling Active Pharmaceutical Ingredient and Drug Reserve (RAPID Reserve) Act (identical legislation); Reauthorization of the Protecting Americans from All-Hazards Preparedness Act (PAHPA) (formerly Pandemics and All-Hazards Preparedness Act).
LobbyistsVALERIE HARDIN JEWETT · JOHN FUNDERBURK
TargetedSENATE · HOUSE OF REPRESENTATIVES · Office of Management & Budget (OMB) · Defense, Dept of (DOD) · Health & Human Services, Dept of (HHS) · Natl Economic Council (NEC)
